MSD has announced interim results of a trial involving anti-PD-1 antibody KEYTRUDA (pembrolizumab) for the treatment of bladder cancer. …
Latest Video
New Stories
-
Merck's Leah Goodman says the 'long term' is now
May 20, 2019 - - PharmaDispatch Executive -
Celltrion announces global expansion plan
May 20, 2019 - - Latest News -
Who predicted this?
May 20, 2019 - - Latest News -
PharmaDispatch 2019: Election outcome an early focus
May 20, 2019 - - Latest News -
Is it really a National Medicines Policy?
May 17, 2019 - - Latest News -
Labor commits funding to boost HCV uptake
May 17, 2019 - - Latest News -
CSL appoints new operations leader
May 17, 2019 - - Latest News